Boothbay Fund Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-9,552
| Closed | -$1.44M | – | 2518 |
|
2022
Q3 | $1.44M | Buy |
+9,552
| New | +$1.44M | 0.04% | 622 |
|
2022
Q2 | – | Sell |
-7,356
| Closed | -$872K | – | 2590 |
|
2022
Q1 | $872K | Buy |
+7,356
| New | +$872K | 0.02% | 785 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 2257 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2202 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 1820 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 1478 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1280 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1118 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 1136 |
|
2019
Q4 | – | Sell |
-10,142
| Closed | -$423K | – | 1050 |
|
2019
Q3 | $423K | Sell |
10,142
-9,218
| -48% | -$384K | 0.04% | 427 |
|
2019
Q2 | $848K | Buy |
+19,360
| New | +$848K | 0.08% | 232 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 903 |
|
2018
Q4 | – | Sell |
-14,665
| Closed | -$551K | – | 969 |
|
2018
Q3 | $551K | Buy |
+14,665
| New | +$551K | 0.05% | 242 |
|
2018
Q2 | – | Sell |
-11,358
| Closed | -$293K | – | 904 |
|
2018
Q1 | $293K | Buy |
+11,358
| New | +$293K | 0.03% | 376 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 837 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 820 |
|